<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Research | Kurnikova Research Group</title>
  <link rel="stylesheet" href="../static/style.css" />
</head>
<body>
  <header>
    <h1>Kurnikova Research Group</h1>
    <p><i>The Biomolecular Modeling Group</i></p>
    <nav>
      <a href="../index.html">Home</a>
      <a href="research.html" class="active">Research</a>
      <a href="publication.html">Publications</a>
      <a href="software.html">Software</a>
      <a href="member.html">Group</a>
      <a href="apply.html">Apply</a>
    </nav>
  </header>

  <main>
    <section class="research-header">
      <h2>Research</h2>
      <div class="research-links">
        <p><a href="#">Ion Channel and Receptor Modeling and Simulations</a></p>
        <p><a href="#">In Silico Drug Discovery</a></p>
      </div>
    </section>

    <section class="drug-discovery">
      <h3><i>In Silico</i> Drug Discovery</h3>
      <img src="../static/image/silico.jpg" alt="In Silico Drug Discovery Workflow" class="workflow-img" />

      <p>
        We have developed several high-throughput binding free energy simulation workflows for drug discovery. 
        We utilize high-throughput absolute binding free energy simulation for hit discovery and relative binding 
        free energy simulations combined with our active learning workflow for lead optimization. Combined, we 
        utilized these workflows to win 1st place in the CACHE Challenge #1, an international computational drug 
        discovery competition, where we and our collaborators discovered 14 novel inhibitors to the challenging 
        leucine-rich repeat kinase 2 (LRRK2) WDR domain, an understudied Parkinson's disease drug target with 
        no known molecular inhibitors prior to our work.
      </p>

      <ol>
        <li>
          Active Learning Guided Drug Design Lead Optimization Based on Relative Binding Free Energy Modeling., 
          Gusev F, Gutkin E, Kurnikova MG, Isayev O., 
          <strong>J. Chem. Inf. Model.</strong> 63(2) pp 583–594, <strong>(2023)</strong>
        </li>
        <li>
          In silico screening of LRRK2 WDR domain inhibitors using deep docking and free energy simulations, 
          Gutkin, E; Gusev, F; Gentile, F; Ban, F; Koby, SB; Narangoda, C; Isayev, O; Cherkasov, A; Kurnikova, M.G., 
          DOI: 10.1039/D3SC06880C, 
          <strong>Chem. Sci.</strong>, Advance Article <strong>(2024)</strong>
        </li>
      </ol>
    </section>

    <section class="enzyme-simulation">
      <h3>Enzyme Simulation for Biocatalysis</h3>
      <!-- Add content later -->
    </section>
  </main>

  <footer>
    <p><strong>Contact kurnikova@andrew.cmu.edu to get more information</strong></p>
    <p>Copyright © 2018–2024 Kurnikova Group, Chemistry Department, Carnegie Mellon University</p>
  </footer>

  <script src="../static/script.js"></script>
</body>
</html>
